Acute Effects of Calcineurin Inhibitors on Kidney Allograft Microperfusion Visualized by Contrast-Enhanced Sonography
Authors:
- Lars P. KihmLKLars P. Kihm
- Carsten BlumeCBCarsten Blume
- Jörg SeckingerJSJörg Seckinger
- Vinzent HankelVHVinzent Hankel
- Dominik StofflerDSDominik Stoffler
- Christian MorathCMChristian Morath
- Martin ZeierMZMartin Zeier
- Vedat SchwengerVSVedat Schwenger
- 15 June 2012
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Transplantation
- Vol. 93 (11) , 1125-1129
Abstract
Calcineurin inhibitors induce detrimental vascular remodeling, which may be one cause of chronic allograft failure. Real-time contrast-enhanced sonography (CES) is a relatively new technique in providing quantitative information on microvascular tissue perfusion in kidney allografts in more detail. The purpose of the study was to explore whether acute changes of kidney allograft microperfusion due to the administration of cyclosporine A (CsA) and tacrolimus (Tac) can be evidenced using real-time CES. In an explorative single-center clinical trial, renal parenchymal tissue perfusion of 32 stable kidney allograft recipients was evaluated with CES before and 2 hr after the intake of CsA or Tac. In addition to laboratory and clinical parameters, Doppler indices and estimated glomerular filtration rate were measured. Although systolic and diastolic blood pressure and color Doppler indices did not significantly differ, there was a significant decrease of renal blood flow 2 hr after the intake of CsA compared with baseline (4.78±2.31 dB/s, 49%, respectively). In contrast, kidney allograft microperfusion was neither significantly reduced in patients receiving CsA paralleled by calcium channel blockers nor significantly reduced in patients receiving Tac. Furthermore, there was a significant correlation between renal blood flow obtained before drug administration and kidney function. CES revealed a 49% reduction of kidney allograft microperfusion 2 hr after the intake of CsA, which might be abrogated by calcium channel blockers. In comparison to CsA, Tac did not result in a significant decrease of kidney blood flow.Keywords
This publication has 41 references indexed in Scilit:
- Contrast Enhanced Sonography Shows Superior Microvascular Renal Allograft Perfusion in Patients Switched From Cyclosporine A to EverolimusTransplantation, 2009
- Acute pyelonephritis: comparison of diagnosis with computed tomography and contrast‐enhanced ultrasonographyBJU International, 2007
- Real-Time Contrast-Enhanced Sonography of Renal Transplant Recipients Predicts Chronic Allograft NephropathyAmerican Journal of Transplantation, 2006
- Recommandations pour l’utilisation des agents de contraste ultrasonoresJournal de Radiologie, 2005
- Cyclosporin A Inhibits Flow-mediated Activation of Endothelial Nitric-oxide Synthase by Altering Cholesterol Content in CaveolaeJournal of Biological Chemistry, 2004
- NEORAL MONITORING BY SIMPLIFIED SPARSE SAMPLING AREA UNDER THE CONCENTRATION-TIME CURVETransplantation, 1999
- Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506Transplant International, 1998
- Vascular mechanisms of cyclosporin-induced hypertension in the rat.Journal of Clinical Investigation, 1994
- THE ACUTE EFFECT OF FK506 AND CYCLOSPORINE ON ENDOTHELIAL CELL FUNCTION AND RENAL VASCULAR RESISTANCETransplantation, 1992
- Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjectsKidney International, 1989